A $6.5 million contract will allow the Chemical Synthesis Facility (CSF) to continue its work on contraceptive development, especially for male contraceptives.
The U of M’s Minnesota Dental Research Center for Biomaterials and Biomechanics (MDRCBB) has joined a national, collaborative research center focused on improving the development process for pharmaceutical products.
A new study reinforces the need to proactively increase doses of certain medications and closely monitor blood levels over the course of pregnancy in people with epilepsy.
